Women's Health: Amenorrhea/Dysmenorrhea
Conditions
Brief summary
Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia
Interventions
DEVICEDoppler
Doing doppler for women having IUCD associated menorrhagia
Sponsors
Ain Shams University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No
Inclusion criteria
* women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD copper T 380 A insertion
Exclusion criteria
* history of bleeding tendency * history of abnormal uterine bleeding due to other causes * history of active liver disease * history of antiplatelet or anticoagulant intake in the last month * history of thyroid disease * history of endometritis * history of allergy to NSAIDs * Adenomyosis * women having contraindications to use NSAIDs e.g. peptic ulcer * Insulin dependant diabetes mellitus
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia) | 1 year | Base line uterine artery doppler is done to the patient complaining of IUCD related menorrhagia prior to treatment , parameters of doppler are: resistance index and pulsitality index, then the patient takes mefenamic acid tablets 500 mg three times daily for five days, assessment of response whether the patient is responder or not is done using pictorial blood loss assessment chart then base line doppler parameters in responders and non responders are compared to correlate the response to base line doppler parameters |
Countries
Egypt
Outcome results
None listed